financetom
Business
financetom
/
Business
/
Siyata Mobile Shares Are On The Rise Friday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Siyata Mobile Shares Are On The Rise Friday: What's Going On?
Dec 27, 2024 1:01 PM

Siyata Mobile Inc. ( SYTA ) shares are trading higher on Friday, possibly following the company’s announcement of a 1-for-10 reverse stock split on Tuesday.

What To Know: The move is aimed at maintaining compliance with Nasdaq’s $1 minimum bid price requirement. The reverse stock split will be effective on Dec. 27, 2024, with trading on a post-split basis commencing the same day under the ticker symbol “SYTA.”

The reverse stock split consolidates every 10 existing shares into one new share. Outstanding stock options, warrants and other convertible securities will also be adjusted to reflect the new ratio. No fractional shares will be issued, with fractions rounded up to the nearest whole number.

Siyata, a global provider of Push-to-Talk over Cellular devices and cellular signal boosters, clarified that the split does not affect the par value or authorized number of shares. The transfer agent, Computershare, will handle the exchange process for registered shareholders. Those holding shares electronically or through brokers will have their positions adjusted automatically.

Despite the stock price jump, the company warned there is no guarantee it will maintain compliance with the minimum bid price requirement after the split.

SYTA Price Action: Siyata Mobile ( SYTA ) shares were up 23.62% at $6.43 at publication Friday, according to Benzinga Pro.

Read Next:

Apple Teases Streaming ‘See For Yourself’ Event: Could This Be A Free Preview Of AppleTV+ Or Ad-Supported Platform?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Gets EU Approval for RNAi Drug to Treat Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Gets EU Approval for RNAi Drug to Treat Transthyretin Amyloidosis With Cardiomyopathy
Jun 9, 2025
06:57 AM EDT, 06/09/2025 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) said Monday the European Commission approved Amvuttra for treating wild-type or hereditary transthyretin amyloidosis with cardiomyopathy in adults. The company said the decision makes Amvuttra the first RNAi therapeutic authorized in the EU for this form of the disease. The approval was based on the Helios-B phase 3...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
IonQ to buy Oxford Ionics for $1.08 billion to expand quantum computing research
IonQ to buy Oxford Ionics for $1.08 billion to expand quantum computing research
Jun 9, 2025
June 9 (Reuters) - IonQ ( IONQ ) will acquire its British peer Oxford Ionics for $1.08 billion, the companies said on Monday, helping the U.S.-based quantum computing firm deepen its research expertise in the complex technology that is seeing booming investor interest. Shares of IonQ ( IONQ ) rose close to 4% premarket. The company was valued at $10.15...
Merck's cholesterol drug meets main goal in late-stage studies
Merck's cholesterol drug meets main goal in late-stage studies
Jun 9, 2025
June 9 (Reuters) - Merck ( MRK ) said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies. (Reporting by Christy Santhosh in Bengaluru; Editing by Shinjini Ganguli) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved